Financial statements Warszawskie Zakłady Farmaceutyczne Polfa Skrót: Warszawskie Zakłady Farmaceutyczne Polfa S.a. Polfa Warszawa S.a.

Balance sheet of Warszawskie Zakłady Farmaceutyczne Polfa Skrót: Warszawskie Zakłady Farmaceutyczne Polfa S.a. Polfa Warszawa S.a.

Company age:
Age:
22 y. 8 m. 7 d.
Share capital:
Share capital:
230 000 000 PLN

Balance sheet data of WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA SKRÓT: WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA S.A. POLFA WARSZAWA S.A.

Year
2018
2019
2020
Total assets 1 003 302,00 1 152 480,00 718 233,00
A. Fixed assets 468 634,00 185 348,00 201 765,00
B. Current assets 534 668,00 967 132,00 516 468,00
C. Share capital contributions (basic funds) 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00
Total liabilities 1 003 302,00 1 152 480,00 718 233,00
A. Equity 879 440,00 966 453,00 556 725,00
B. Liabilities and provisions for liabilities 123 862,00 186 027,00 161 508,00
I. Long-term liabilities 32,00 14,00 9,00
II. Short-term liabilities 107 376,00 141 741,00 114 324,00
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.